Opinion
Brian Robins: The ‘Aussie Premium’ baked into NZX stocks
New Zealand entities launching in Australia have clear benefits.
Opinion
Brian Robins: Aroa comes unstuck thanks to US partnership
The Auckland-based medtech firm is under pressure.
Opinion
Brian Robins: Surviving Trump's ‘whack-a-mole’ tariffs
Trump's end game is to curtail China's trade position.
Opinion
Brian Robins: Xero to hero: What CEO pay move says about ASX listing
The catalysts Xero needed: executive pay alignment and ambitious growth strategies.
